Fundamental dimension Equity attribute | BBIOPeer $68.56▲+0.65% Cap $13.40BP/E -19.2x QuantScore51/100 | ALNYPeer $233.29▲+0.63% Cap $31.22BP/E 38.2x QuantScore70/100 | ASNDLeader $243.37▲+0.16% Cap $15.18BP/E 18.0x QuantScore73/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
61/100 |
57/100 |
94/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 38/100 | 46/100 |
Health Piotroski, Altman Z, leverage & liquidity | 28/100 | 61/100 | 71/100 |
Growth Revenue / earnings growth & margins | 80/100 | 100/100 | 97/100 |
Sentiment Analyst ratings, targets & revisions | 83/100 | 92/100 | 59/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -19.2x | 38.2x | 18.0x |
Forward P/E (next FY) | -24.9x | 35.1x | 16.6x |
EV / EBITDA (TTM) | -24.9x | 26.7x | 168.8x |
Price / Sales | 18.8x | 6.5x | 12.8x |
Price / Free Cash Flow | -30.5x | 57.5x | 40.2x |
PEG ratio | -1.49 | 0.01 | 0.03 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 6 / 9 | 6 / 9 |
Altman Z-Score | -3.49 (Distress) | 5.02 (Safe) | 9.44 (Safe) |
Total debt / equity | -0.99 | 0.94 | 0.31 |
Quick ratio | 1.2x | 3.0x | 2.3x |
Interest coverage | -6.0x | 3.1x | 0.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +126.3% | +65.2% | +90.2% |
Net income growth YoY | -36.1% | +212.8% | +42.1% |
Gross margin (TTM) | 93.3% | 79.7% | 90.2% |
Operating margin (FY) | -113.3% | 13.5% | -18.9% |
FCF margin (FY) | -89.0% | 12.5% | 6.3% |
5. Trailing price performancePrice change over period |
1M return | +3.4% | -2.6% | +5.5% |
3M return | -18.4% | -12.8% | -4.1% |
6M return | -6.4% | -24.7% | +6.1% |
Year to date | -10.4% | -41.3% | +14.1% |
1Y return | +26.4% | -52.5% | +20.5% |
3Y return | +173.5% | +45.4% | +176.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-128.59 -287.6% premium | $-1,482.46 -735.5% premium | $-4,376.72 -1898.4% premium |
Wall Street consensus target | $112.83 +64.6% · range $87.00–$156.00 | $347.23 +48.8% · range $253.00–$455.00 | $311.17 +27.9% · range $269.00–$344.00 |
Consensus stance | 89% Buy11% Hold-0% Sell | 75% Buy23% Hold2% Sell | 92% Buy8% Hold0% Sell |